Vesigen Therapeutics, Inc.的封面图片
Vesigen Therapeutics, Inc.

Vesigen Therapeutics, Inc.

生物技术研究

Cambridge,Massachusetts 4,670 位关注者

Delivering intracellular therapeutics with ARMMed microvesicles

关于我们

Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.

网站
https://www.vesigen.com/
所属行业
生物技术研究
规模
11-50 人
总部
Cambridge,Massachusetts
类型
私人持股

地点

  • 主要

    790 Memorial Dr

    Suite 103

    US,Massachusetts,Cambridge,02139

    获取路线

Vesigen Therapeutics, Inc.员工

动态

相似主页

查看职位

融资